WAM
ASND icon

Wolverine Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Wolverine Asset Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,700
Closed -$159K – 1789
2023
Q3 		$159K Hold
1,700
– – ﹤0.01% 1081
2023
Q2 		$152K Buy
1,700
+700
+70% +$60.9K ﹤0.01% 1024
2023
Q1 		$107K Buy
1,000
+500
+100% +$57.2K ﹤0.01% 1108
2022
Q4 		$61.1K Sell
500
-40,700
-99% -$4.73M ﹤0.01% 1356
2022
Q3 		$4.25M Buy
41,200
+500
+1% +$47.4K 0.05% 354
2022
Q2 		$3.78M Hold
40,700
– – 0.04% 385
2022
Q1 		$4.78M Buy
+40,700
New +$4.71M 0.05% 298

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return